中华医学杂志
中華醫學雜誌
중화의학잡지
National Medical Journal of China
2008年
36期
2550-2552
,共3页
茅江峰%伍学焱%李乃适%卢双玉%金自孟%史轶蘩
茅江峰%伍學焱%李迺適%盧雙玉%金自孟%史軼蘩
모강봉%오학염%리내괄%로쌍옥%금자맹%사질번
性功能障碍%青少年%睾酮
性功能障礙%青少年%睪酮
성공능장애%청소년%고동
Sex disorders%Adolescence%Testosterone
目的 评价短期睾酮替代治疗对性腺功能减退症青少年男性胰岛素敏感性的影响.方法 (1)比较胰岛素抵抗指数(HOMA-IR)在性腺功能减退症青少年男性(n=21)与健康男性(n=18)之间的差异.(2)对患病组行9个月的睾酮替代治疗,比较治疗前后体重、腹围、握力、体脂含量、血总睾酮水平(TT)、空腹血糖和胰岛素、血脂谱和超敏C反应蛋白(hsCRP)的变化.结果 (1)睾酮替代治疗前:患病组平均TT(0.9±0.6)nmol/L,明显低于健康组(18.8±3.2)nmol/L;患病组中有3例诊断为糖耐量受损,健康组中无糖耐量受损或糖尿病;患病组空腹胰岛素水平显著高于健康组,[(16.0±9.8)mIU/L vs(8.4±3.3)mIU/L,P=0.018)];患病组HOMA-IR显著高于对照组,(3.7±2.4 vs 1.8±0.7,P=0.021);(2)患病组经睾酮替代治疗后,空腹胰岛素水平下降[(16.0±9.8)mIU/L vs 12.1±7.4)mIU/L,P=0.03)];HOMA-IR从3.7±2.4下降到2.7±1.7(P=0.045);总胆固醇和甘油三酯都有下降,但差异无统计学意义(P均>0.05).hsCRP从(1.49±1.18)mg/L下降到(0.70±0.56)mg/L(P=0.025).结论 (1)性腺功能减退症患者胰岛素敏感性下降,发生糖代谢异常的风险增加.(2)睾酮替代治疗可改善患者的胰岛素敏感性,降低hsCRP水平.
目的 評價短期睪酮替代治療對性腺功能減退癥青少年男性胰島素敏感性的影響.方法 (1)比較胰島素牴抗指數(HOMA-IR)在性腺功能減退癥青少年男性(n=21)與健康男性(n=18)之間的差異.(2)對患病組行9箇月的睪酮替代治療,比較治療前後體重、腹圍、握力、體脂含量、血總睪酮水平(TT)、空腹血糖和胰島素、血脂譜和超敏C反應蛋白(hsCRP)的變化.結果 (1)睪酮替代治療前:患病組平均TT(0.9±0.6)nmol/L,明顯低于健康組(18.8±3.2)nmol/L;患病組中有3例診斷為糖耐量受損,健康組中無糖耐量受損或糖尿病;患病組空腹胰島素水平顯著高于健康組,[(16.0±9.8)mIU/L vs(8.4±3.3)mIU/L,P=0.018)];患病組HOMA-IR顯著高于對照組,(3.7±2.4 vs 1.8±0.7,P=0.021);(2)患病組經睪酮替代治療後,空腹胰島素水平下降[(16.0±9.8)mIU/L vs 12.1±7.4)mIU/L,P=0.03)];HOMA-IR從3.7±2.4下降到2.7±1.7(P=0.045);總膽固醇和甘油三酯都有下降,但差異無統計學意義(P均>0.05).hsCRP從(1.49±1.18)mg/L下降到(0.70±0.56)mg/L(P=0.025).結論 (1)性腺功能減退癥患者胰島素敏感性下降,髮生糖代謝異常的風險增加.(2)睪酮替代治療可改善患者的胰島素敏感性,降低hsCRP水平.
목적 평개단기고동체대치료대성선공능감퇴증청소년남성이도소민감성적영향.방법 (1)비교이도소저항지수(HOMA-IR)재성선공능감퇴증청소년남성(n=21)여건강남성(n=18)지간적차이.(2)대환병조행9개월적고동체대치료,비교치료전후체중、복위、악력、체지함량、혈총고동수평(TT)、공복혈당화이도소、혈지보화초민C반응단백(hsCRP)적변화.결과 (1)고동체대치료전:환병조평균TT(0.9±0.6)nmol/L,명현저우건강조(18.8±3.2)nmol/L;환병조중유3례진단위당내량수손,건강조중무당내량수손혹당뇨병;환병조공복이도소수평현저고우건강조,[(16.0±9.8)mIU/L vs(8.4±3.3)mIU/L,P=0.018)];환병조HOMA-IR현저고우대조조,(3.7±2.4 vs 1.8±0.7,P=0.021);(2)환병조경고동체대치료후,공복이도소수평하강[(16.0±9.8)mIU/L vs 12.1±7.4)mIU/L,P=0.03)];HOMA-IR종3.7±2.4하강도2.7±1.7(P=0.045);총담고순화감유삼지도유하강,단차이무통계학의의(P균>0.05).hsCRP종(1.49±1.18)mg/L하강도(0.70±0.56)mg/L(P=0.025).결론 (1)성선공능감퇴증환자이도소민감성하강,발생당대사이상적풍험증가.(2)고동체대치료가개선환자적이도소민감성,강저hsCRP수평.
Objective To evaluate the effect of testosterone replacement thempy in patients with hypogonatrophic hypogonadism(HH)on insulin sensitivity and high sensitivity C reactive protein(hsCRP).Methods 21 males with HH,aged 15-30,and 18 age,and BMI-matched healthy males underwent detection of homeostasis model assessment insulin resistance index(HOMA-IR).Second,the values of weight,abdominal circumstance,gips strength,body composition,total testosterone(TT),fast blood glucose and insulin,serum lipid profile,and hsCRP were compared before and after 9-month testosterone replacement therapy in the HH patient group.Results(1)Before treatment the TT level of the HH patients WAS(0.9±0.6)nmol/L,significantly lower than that of the healthy control group(18.8±3.2)nmol/L.The fast insulin level of the HH patients was(16.0±9.8)mIU/L,significantly higher than that of the control group[(8.4±3.3)mIU/L,P=0.018].The HOMA-IR of the HH patient was 3.7±2.4,not significantly different from that of the control group(1.8±0.7,P=0.021).(2)After testosterone therapy,the fast insulin level of the HH patients decreased from(16.0±9.8)mIU/L to(12.1±7.4)mIU/L(P=0.03);the HOMA-IR decreased from(3.7±2.4)to(2.7±1.7)(P=0.045);and the total cholesterol,LDL-c,HDL-c,and Triglyceride all decreased,but not significantly(all P>0.05).The hsCRP decreased from(1.49±1.18)mg/L to(0.70±0.56)mg/L(P=0.025).Conclusion Short period of testosterone replacement therapy in young HH male patients significantly improves the insulin sensitivity and decreases the risk of cardiovascular disease.